| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.023 | 0.9 |